Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation.

Rayes, N; Seehofer, D; Schmidt, C A; Oettle, H; Müller, A R; Steinmüller, T; Settmacher, U; Bechstein, W O; Neuhaus, P

Rayes, N; Seehofer, D; Schmidt, C A; Oettle, H; Müller, A R; Steinmüller, T; Settmacher, U; Bechstein, W O; Neuhaus, P.

Affiliation

Rayes N; Department of Surgery, Charité Campus Virchow, Augustenburger Platz 1, 13355 Berlin, Germany.

Transplantation ; 72(5): 881-5, 2001 Sep 15.

Article in En | MEDLINE | ID: mdl-11571454

Subject(s)

Antiviral Agents/administration & dosage; Cytomegalovirus Infections/drug therapy; Ganciclovir/administration & dosage; Liver Transplantation/adverse effects; Administration, Oral; Antiviral Agents/adverse effects; Cytomegalovirus Infections/etiology; Cytomegalovirus Infections/mortality; Female; Ganciclovir/adverse effects; Humans; Injections, Intravenous; Male; Middle Aged; Phosphoproteins/blood; Prospective Studies; Recurrence; Reoperation; Survival Rate; Viral Matrix Proteins/blood; Viremia/drug therapy; Viremia/etiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Liver Transplantation / Cytomegalovirus Infections Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2001 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links